Labcorp Holdings Share Holder Equity 2012-2025 | LH
Labcorp Holdings share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
- Labcorp Holdings share holder equity for the quarter ending September 30, 2025 was $8.697B, a 6.45% increase year-over-year.
- Labcorp Holdings share holder equity for 2024 was $8.052B, a 2.25% increase from 2023.
- Labcorp Holdings share holder equity for 2023 was $7.875B, a 22% decline from 2022.
- Labcorp Holdings share holder equity for 2022 was $10.097B, a 1.72% decline from 2021.
|
Labcorp Holdings Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $8,052 |
| 2023 | $7,875 |
| 2022 | $10,097 |
| 2021 | $10,273 |
| 2020 | $9,437 |
| 2019 | $7,567 |
| 2018 | $6,971 |
| 2017 | $6,804 |
| 2016 | $5,506 |
| 2015 | $4,945 |
| 2014 | $2,821 |
| 2013 | $2,491 |
| 2012 | $2,717 |
| 2011 | $2,504 |
|
Labcorp Holdings Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-09-30 | $8,697 |
| 2025-06-30 | $8,473 |
| 2025-03-31 | $8,307 |
| 2024-12-31 | $8,052 |
| 2024-09-30 | $8,170 |
| 2024-06-30 | $8,006 |
| 2024-03-31 | $7,960 |
| 2023-12-31 | $7,875 |
| 2023-09-30 | $7,873 |
| 2023-06-30 | $8,785 |
| 2023-03-31 | $10,342 |
| 2022-12-31 | $10,097 |
| 2022-09-30 | $10,092 |
| 2022-06-30 | $10,401 |
| 2022-03-31 | $10,721 |
| 2021-12-31 | $10,273 |
| 2021-09-30 | $10,525 |
| 2021-06-30 | $10,245 |
| 2021-03-31 | $10,022 |
| 2020-12-31 | $9,437 |
| 2020-09-30 | $8,239 |
| 2020-06-30 | $7,353 |
| 2020-03-31 | $7,020 |
| 2019-12-31 | $7,567 |
| 2019-09-30 | $7,231 |
| 2019-06-30 | $7,144 |
| 2019-03-31 | $7,111 |
| 2018-12-31 | $6,971 |
| 2018-09-30 | $7,248 |
| 2018-06-30 | $7,038 |
| 2018-03-31 | $6,984 |
| 2017-12-31 | $6,804 |
| 2017-09-30 | $6,126 |
| 2017-06-30 | $5,878 |
| 2017-03-31 | $5,651 |
| 2016-12-31 | $5,506 |
| 2016-09-30 | $5,523 |
| 2016-06-30 | $5,313 |
| 2016-03-31 | $5,167 |
| 2015-12-31 | $4,945 |
| 2015-09-30 | $4,914 |
| 2015-06-30 | $4,770 |
| 2015-03-31 | $4,518 |
| 2014-12-31 | $2,821 |
| 2014-09-30 | $2,771 |
| 2014-06-30 | $2,656 |
| 2014-03-31 | $2,501 |
| 2013-12-31 | $2,491 |
| 2013-09-30 | $2,566 |
| 2013-06-30 | $2,663 |
| 2013-03-31 | $2,778 |
| 2012-12-31 | $2,717 |
| 2012-09-30 | $2,717 |
| 2012-06-30 | $2,632 |
| 2012-03-31 | $2,598 |
| 2011-12-31 | $2,504 |
| 2011-09-30 | $2,543 |
| 2011-06-30 | $2,580 |
| 2011-03-31 | $2,400 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $22.455B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $166.692B | 30.61 |
| HCA Healthcare (HCA) | United States | $107.089B | 17.73 |
| CVS Health (CVS) | United States | $99.777B | 11.47 |
| Elevance Health (ELV) | United States | $83.311B | 12.22 |
| Cencora (COR) | United States | $68.838B | 22.19 |
| Natera (NTRA) | United States | $31.987B | 0.00 |
| DiDi Global (DIDIY) | China | $23.485B | 21.70 |
| Medpace Holdings (MEDP) | United States | $17.208B | 42.72 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.445B | 0.00 |
| Viatris (VTRS) | United States | $14.812B | 5.52 |
| BioMerieux (BMXMF) | France | $14.802B | 0.00 |
| ICON (ICLR) | Ireland | $14.747B | 14.63 |
| Solventum (SOLV) | United States | $13.786B | 13.38 |
| Revvity (RVTY) | United States | $12.755B | 23.49 |
| CochLear (CHEOY) | Australia | $11.760B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.813B | 20.82 |
| Avantor (AVTR) | United States | $8.291B | 12.67 |
| Sonic Healthcare (SKHHY) | Australia | $7.752B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.556B | 0.00 |
| HealthEquity (HQY) | United States | $7.294B | 27.27 |
| BrightSpring Health Services (BTSG) | United States | $7.070B | 42.15 |
| Bausch + Lomb (BLCO) | Canada | $6.078B | 39.91 |
| PACS (PACS) | United States | $6.072B | 36.92 |
| Sotera Health (SHC) | United States | $5.449B | 26.27 |
| Alignment Healthcare (ALHC) | United States | $4.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.124B | 54.86 |
| Concentras Parent (CON) | United States | $2.762B | 17.24 |
| Organon (OGN) | United States | $2.277B | 2.40 |
| Progyny (PGNY) | United States | $2.114B | 41.56 |
| Surgery Partners (SGRY) | United States | $2.057B | 26.50 |
| Establishment Labs Holdings (ESTA) | United States | $1.962B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.877B | 11.21 |
| Ardent Health (ARDT) | United States | $1.231B | 4.02 |
| Teladoc Health (TDOC) | United States | $1.115B | 0.00 |
| Nutex Health (NUTX) | United States | $1.080B | 8.26 |
| CareDx (CDNA) | United States | $1.029B | 16.82 |
| Omada Health (OMDA) | United States | $0.933B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.910B | 14.89 |
| InnovAge Holding (INNV) | United States | $0.794B | 0.00 |
| Embecta (EMBC) | United States | $0.734B | 4.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.706B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.594B | 0.00 |
| CryoPort (CYRX) | United States | $0.552B | 0.00 |
| Enhabit (EHAB) | United States | $0.532B | 23.91 |
| Strata Critical Medical (SRTA) | United States | $0.515B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.445B | 8.19 |
| Agilon Health (AGL) | United States | $0.423B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.51 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.288B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.279B | 58.75 |
| So-Young (SY) | China | $0.269B | 0.00 |
| KindlyMD (NAKA) | United States | $0.201B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.181B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.141B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.046B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.21 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.016B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |